Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2012 1
2014 2
2015 8
2016 7
2017 12
2018 14
2019 16
2020 12
2021 16
2022 19
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization.
Zhao J, Li X, Hu J, Chen F, Qiao S, Sun X, Gao L, Xie J, Xu B. Zhao J, et al. Cardiovasc Res. 2019 Jun 1;115(7):1205-1216. doi: 10.1093/cvr/cvz040. Cardiovasc Res. 2019. PMID: 30753344 Free PMC article.
This study sheds new light on the application of MSC-Exo as a potential therapeutic tool for myocardial I/R injury....
This study sheds new light on the application of MSC-Exo as a potential therapeutic tool for myocardial I/R injury....
Autologous serum eye drops for dry eye.
Pan Q, Angelina A, Marrone M, Stark WJ, Akpek EK. Pan Q, et al. Cochrane Database Syst Rev. 2017 Feb 28;2(2):CD009327. doi: 10.1002/14651858.CD009327.pub3. Cochrane Database Syst Rev. 2017. PMID: 28245347 Free PMC article. Review.
Therapeutic applications of toll-like receptors (TLRs) agonists in AML.
Peng Y, Wang Y, Wang M, Lan J, Chen Y. Peng Y, et al. Clin Transl Oncol. 2022 Dec;24(12):2319-2329. doi: 10.1007/s12094-022-02917-5. Epub 2022 Aug 13. Clin Transl Oncol. 2022. PMID: 35962918 Review.
This study aimed to review the current knowledge in this field and provide some insight into the therapeutic potentials of TLRs in AML....
This study aimed to review the current knowledge in this field and provide some insight into the therapeutic potentials of TLRs in AM …
Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway.
Xia W, Chen W, Ni C, Meng X, Wu J, Yang Q, Tang H, Yuan H, Fang S. Xia W, et al. Breast Cancer Res. 2023 Jul 17;25(1):85. doi: 10.1186/s13058-023-01672-x. Breast Cancer Res. 2023. PMID: 37461019 Free PMC article.
CONCLUSIONS: These results demonstrated that PTX-induced exosomal circBACH1 promoted stemness and migration of BC cells by sponging miR-217 to upregulate the expression of G3BP2, which provided a new therapeutic target for PTX-resistance and progression of BC via circBACH1 …
CONCLUSIONS: These results demonstrated that PTX-induced exosomal circBACH1 promoted stemness and migration of BC cells by sponging miR-217 …
Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis.
Liu B, Song A, Gui P, Wang J, Pan Y, Li C, Li S, Zhang Y, Jiang T, Xu Y, Pei D, Song J. Liu B, et al. Cell Death Dis. 2023 Jul 14;14(7):427. doi: 10.1038/s41419-023-05924-8. Cell Death Dis. 2023. PMID: 37452042 Free PMC article.
In summary, this study highlights a novel CRC biomarker and therapeutic target, LINC01594, and the findings suggest that the LINC01594-CELF6-CD44 axis might serve as a biomarker and therapeutic target in CRC....
In summary, this study highlights a novel CRC biomarker and therapeutic target, LINC01594, and the findings suggest that the LINC0159 …
Overexpression of blaGES-1 due to a strong promoter in the class 1 integron contributes to decreased ceftazidime-avibactam susceptibility in carbapenem-resistant Pseudomonas aeruginosa ST235.
Li X, Zhang X, Cai H, Zhu Y, Ji J, Qu T, Tu Y, Zhou H, Yu Y. Li X, et al. Drug Resist Updat. 2023 Jul;69:100973. doi: 10.1016/j.drup.2023.100973. Epub 2023 May 2. Drug Resist Updat. 2023. PMID: 37148599
Moreover, such overexpression of bla(GES-1) combined with an efflux pump resulted in high-level resistance to CZA, considerably reducing the therapeutic options available for treating infections caused by ST235 CRPA. ...
Moreover, such overexpression of bla(GES-1) combined with an efflux pump resulted in high-level resistance to CZA, considerably reducing the …
Neo-Antigen-Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach.
Chen GL, Kong DX, Lin Y. Chen GL, et al. Glob Chall. 2023 Oct 17;7(11):2200186. doi: 10.1002/gch2.202200186. eCollection 2023 Nov. Glob Chall. 2023. PMID: 37970536 Free PMC article. Review.
This review summarized the properties of neoantigens as well as the preparation and therapeutic outcomes of NRTs for the treatment of CRC....
This review summarized the properties of neoantigens as well as the preparation and therapeutic outcomes of NRTs for the treatment of …
110 results